Research use onlyVeytralis (TR)
Peptide analog
10mg, 20mg
Out of stock
Available
$110.00
Research use only · Not for human or veterinary use
Veytralis (RT)
Mass
Out of stock
$75.00
$75.00/vial
Quantity
1
Analytical documentation
10mg · Report LQ6E available via COA
Estimated arrival · 2–8 calendar days from ordering
Estimated delivery window · shipping rates shown at checkout
Overnight and two-day options
Select DHL Ground, 2Day or Next Day at checkout
Secure encrypted checkout
Veytralis (RT) is supplied for controlled laboratory investigation and analytical work. Nominal amount: 10mg. Ingredient identity: Retatrutide. For in vitro laboratory research only; not for human, animal, veterinary or clinical use. Qualified researchers 21+ only.
This product is supplied strictly for in vitro laboratory research. Not for human, animal, veterinary, therapeutic, diagnostic or clinical use. By purchasing, you confirm you are a qualified researcher aged 21 or older.
Explore the catalog
Related research compounds
Research use only
Research use only
Research use only
Research use onlyMelanotan 2 (MT2)
Cyclic peptide analog
10mg
Available
$39.00
Research use only · Not for human or veterinary use
Box and quantity options
Reported test results
Published batch results
Results apply only to the tested laboratory lot and do not confirm the lot that will ship. Request current lot documentation where needed.
Certificate of analysis · LQ6E
Retatrutide 99.72%
Reported purity
- Lot
- DPS-6373036
- Tested
- September 16, 2026
- Labeled
- 10mg
- Measured
- 9.91mg
Certificate summary · 10mg
Lot-specific- PurityReported by laboratory
- Retatrutide 99.72%
- Quantity resultMeasured
- 9.91mg
- Labeled amountNominal
- 10mg
- IdentityCompound tested
- Retatrutide
- Laboratory lotLab identifier
- DPS-6373036
- Analysis dateReport date
- September 16, 2026
Published certificate history
Open any lot's certificate. Each record applies only to its exact strength and lot.
Veytralis (RT) 10mg
Newest reportCertificate LQ6E
Retatrutide 99.72%
- Labeled
- 10mg
- Measured
- 9.91mg
- Lot
- DPS-6373036
- Tested
- September 16, 2026
Veytralis (RT) 20mg
Newest reportCertificate 5J6B
Retatrutide 99.61%
- Labeled
- 20mg
- Measured
- 19.67mg
- Lot
- DPS-3766704
- Tested
- September 16, 2026
Veytralis (RT) 20mg
Certificate 9BWV
Retatrutide 99.47% ± 0.18%
- Labeled
- 20mg
- Measured
- 21.14mg
- Lot
- 00001
- Tested
- June 11, 2026
Veytralis (RT) 60mg
Newest reportCertificate WQXV
Retatrutide 99.78% ± 0.18%
- Labeled
- 60mg
- Measured
- 65.31mg
- Lot
- 00001
- Tested
- June 11, 2026
Technical specifications
Compound information
Selected specification
Veytralis (RT)
- Nominal amount
- 10mg
- Commerce SKU
- VYT-RET-10MG
- Availability
- In stock
Technical specifications
Ingredient identity: Retatrutide. Classification: peptide research compound. Nominal amount is specified by the selected variation; it is not a measured batch result.
Batch documentation
Review the certificate for the exact ingredient, strength and laboratory lot. Purity and measured quantity apply only to that tested lot. Archived certificates do not confirm the lot that will ship; request current lot documentation.
Research restrictions
For in vitro laboratory research only. Not for human, animal, veterinary, clinical or diagnostic use. Qualified researchers aged 21 or older only.
Important research notice
Not for human, animal or veterinary use. This product is offered solely for laboratory research and analytical use. It is not intended for human or veterinary use, clinical use, diagnosis, treatment, cure, or prevention of disease. No dosing, administration, or therapeutic claims are made in this listing.
Refer to applicable product documentation, certificate of analysis, lot information, and applicable laws and regulations before use in a research setting.
By purchasing, you confirm you are a qualified researcher aged 21 or older.